The REG1 Anticoagulation System: A Novel Actively Controlled Factor Ix Inhibitor Using RNA Aptamer Technology for Treatment of Acute Coronary Syndrome
John P. Vavalle(Clinical Research Institute), Mauricio G. Cohen(Santa Ana College)
Cited by 47
Related Papers
Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association
|Circulation|2017|1.8k
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization
|Journal of the American College of Cardiology|2021|1.5k
Predictive Factors, Management, and Clinical Outcomes of Coronary Obstruction Following Transcatheter Aortic Valve Implantation
|Journal of the American College of Cardiology|2013|643
An Update on Radial Artery Access and Best Practices for Transradial Coronary Angiography and Intervention in Acute Coronary Syndrome: A Scientific Statement From the American Heart Association
|Circulation Cardiovascular Interventions|2018|519